Comparison of composition and absorption of sugarcane policosanols
Authors:
- Christopher P. F. MarinangeliCMChristopher P. F. Marinangeli
- Amira N. KassisAKAmira N. Kassis
- Deepak JainDJDeepak Jain
- Naoyuki EbineNENaoyuki Ebine
- Stephen C. CunnaneSCStephen C. Cunnane
- Peter J. H. JonesPJPeter J. H. Jones
- 1 February 2007
- journal article
- research article
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 97 (2) , 381-388
Abstract
Policosanols (PC) exist as very-long-chain alcohols derived from sugarcane currently used in many countries as a cholesterol-lowering therapy. PC purity and relative percentage composition have been suggested as primary reasons why the original Cuban PC (OPC) supplements possess lipid-lowering efficacy. The purpose of the present study was, first, to compare the relative percentage purity and PC composition of both OPC and alternative sources of PC (APC). A second objective was to feed Syrian hamsters a diet containing 0·275 mg PC/g of either the OPC or an APC product (APC1) and compare subsequent tissue, plasma and faecal PC levels. Five animals from the APC1 dietary group received a diet containing ten times the original amount of PC. Results indicate that the APC formulations have a composition that is highly consistent with the OPC supplement, with octacosanol being present within the cited 60–70 % range. PC were undetectable in the small intestine, liver, adipose or plasma in animals fed either source. Hamsters fed OPC excreted octacosanol (C28) more rapidly (P < 0·05) than hamsters receiving APC1. If the cholesterol-lowering efficacy of PC mixtures is dependent on their purity and composition, then sugarcane-derived APC products should possess similar therapeutic properties as the OPC supplement.Keywords
This publication has 47 references indexed in Scilit:
- Policosanol Inhibits Cholesterol Synthesis in Hepatoma Cells by Activation of AMP-KinaseThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Policosanol Has No Antioxidant Activity in Human Low-Density Lipoprotein but Increases Excretion of Bile Acids in HamstersJournal of Agricultural and Food Chemistry, 2005
- Modification of phospholipids fatty acid composition in reuber H35 hepatoma cells: Effect on HMG-CoA reductase activityJournal of Cellular Biochemistry, 2003
- Comparison of the Efficacy and Tolerability of Policosanol with Atorvastatin in Elderly Patients with Type II HypercholesterolaemiaDrugs & Aging, 2003
- Inhibition of cholesterol biosynthesis in cultured fibroblasts by D003, A mixture of very long chain saturated fatty acidsPharmacological Research, 2001
- Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein dietBritish Journal of Nutrition, 1997
- Tissue Distribution of (8-14C)-Octacosanol in Liver and Muscle of Rats after Serial AdministrationAnnals of Nutrition and Metabolism, 1995
- Toxicity of policosanol in beagle dogs: one-year studyToxicology Letters, 1994
- Biodistribution and Metabolism of Orally Administered Octacosanol in RatsAnnals of Nutrition and Metabolism, 1993
- Conclusive evidence that very-long-chain fatty acids are oxidized exclusively in peroxisomes in human skin fibroblastsBiochemical and Biophysical Research Communications, 1991